Cargando…

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′

Detalles Bibliográficos
Autores principales:	McIlroy, James R., Mullish, Benjamin H., Goldenberg, Simon D., Ianiro, Gianluca, Marchesi, Julian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354373/ https://www.ncbi.nlm.nih.gov/pubmed/32663514 http://dx.doi.org/10.1016/j.clim.2020.108542

Ejemplares similares

M. C. McNamara, D.D.S.
Publicado: (1901)

The McNamara fallacy in medical education: Spot it, stop it
por: Hirkani, MA
Publicado: (2023)

McNamara analysis cephalometric parameters in White-Brazilians, Japanese and Japanese-Brazilians with normal occlusion
por: STORNIOLO-SOUZA, Juliana Moura, et al.
Publicado: (2021)

Competency-based medical education and the McNamara fallacy: Assessing the important or making the assessed important?
por: Singh, T, et al.
Publicado: (2023)

Competency-based medical education and the McNamara fallacy: Assessing the important or making the assessed important?
por: Indrayan, A
Publicado: (2023)

Efficacy of a Newly Designed Cephalometric Analysis Software for McNamara Analysis in Comparison with Dolphin Software
por: Nouri, Mahtab, et al.
Publicado: (2015)

Reply to Letter to Editor regarding the article, “Competency-based medical education and the McNamara fallacy: Assessing the important or making the assessed important?”
por: Singh, T, et al.
Publicado: (2023)

Felsenstein Phylogenetic Likelihood
por: Posada, David, et al.
Publicado: (2021)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Renewing Felsenstein’s Phylogenetic Bootstrap in the Era of Big Data
por: Lemoine, F., et al.
Publicado: (2018)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

Distinguishing Felsenstein Zone from Farris Zone Using Neural Networks
por: Leuchtenberger, Alina F, et al.
Publicado: (2020)

Incorporating alignment uncertainty into Felsenstein’s phylogenetic bootstrap to improve its reliability
por: Chang, Jia-Ming, et al.
Publicado: (2019)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

COVID-19 and Book Publishing: Impacts and Insights for 2021
por: Guren, Cliff, et al.
Publicado: (2021)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19
por: Sohrabi, Yahya, et al.
Publicado: (2021)

The role of ibrutinib in COVID-19 hyperinflammation: A case report
por: Maynard, Suzanne, et al.
Publicado: (2021)

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020)

A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19
por: Cothran, Thomas P., et al.
Publicado: (2020)

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
por: TUFAN, Abdurrahman, et al.
Publicado: (2020)

COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps
por: Borges, Leandro, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity
por: Torres-Ruiz, Jiram, et al.
Publicado: (2021)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022)

Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
por: Marwah, Vikas, et al.
Publicado: (2021)

Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors
por: Gasparyan, Armen Yuri, et al.
Publicado: (2022)

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)

Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
por: Clark, Kristina E N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g96m3l51japn8ldjb4bs6h0euf